Lombard Odier Asset Management (Switzerland)’s iShares Biotechnology ETF IBB Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-52,500	Closed	-$5.61M	–	387
2017 Q4	$5.61M	Sell	52,500 -120,000	-70%	-$12.8M	0.54%	45
2017 Q3	$19.2M	Buy	172,500 +88,656	+106%	+$9.48M	1.86%	11
2017 Q2	$8.67M	Sell	83,844 -66,156	-44%	-$6.52M	0.99%	26
2017 Q1	$14.7M	Buy	+150,000	New	+$14.4M	1.63%	14

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s IBB Position: Q1 2018 in Review

Lombard Odier Asset Management (Switzerland) sold out of iShares Biotechnology ETF (IBB) in Q1 2018, closing a stake of 52,500 shares — an estimated $5.61M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in IBB in Q1 2017 and held it in 4 quarters. The position peaked at $19.2M in Q3 2017. 608 funds tracked by Wall St. Rank hold IBB as of Q1 2018.

Lombard Odier Asset Management (Switzerland) reported no remaining iShares Biotechnology ETF position as of Q1 2018 after selling out during the quarter.
Lombard Odier Asset Management (Switzerland) sold 52,500 iShares Biotechnology ETF shares in Q1 2018, an estimated $5.61M.
Lombard Odier Asset Management (Switzerland) first reported a position in iShares Biotechnology ETF in Q1 2017 and held it in 4 quarters.
Lombard Odier Asset Management (Switzerland)'s iShares Biotechnology ETF position peaked at $19.2M in Q3 2017.
608 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2018.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q1 2018, filed 15 May 2018.